Litcius/Paper detail

Multiple strategies enhance the efficacy of MSCs transplantation for spinal cord injury

Qi-Ming Pang, Kua-Qian Deng, Meng Zhang, Xiang-Chong Wu, Ruilin Yang, Sheng-Ping Fu, Feng-Qin Lin, Qian Zhang, Jun Ao, Tao Zhang

2022Biomedicine & Pharmacotherapy26 citationsDOIOpen Access PDF

Abstract

Spinal cord injury (SCI) is a serious complication of the central nervous system (CNS) after spine injury, often resulting in severe sensory, motor, and autonomic dysfunction below the level of injury. To date, there is no effective treatment strategy for SCI. Recently, stem cell therapy has brought hope to patients with neurological diseases. Mesenchymal stem cells (MSCs) are considered to be the most promising source of cellular therapy after SCI due to their immunomodulatory, neuroprotective and angiogenic potential. Considering the limited therapeutic effect of MSCs due to the complex pathophysiological environment following SCI, this paper not only reviews the specific mechanism of MSCs to facilitate SCI repair, but also further discusses the research status of these pluripotent stem cells combined with other therapeutic approaches to promote anatomical and functional recovery post-SCI.

Topics & Concepts

Spinal cord injuryMesenchymal stem cellMedicineNeuroprotectionTransplantationStem-cell therapyNeuroscienceStem cellSpinal cordCentral nervous systemCell therapyInduced pluripotent stem cellBioinformaticsSurgeryPathologyPharmacologyInternal medicineEmbryonic stem cellBiologyBiochemistryGenePsychiatryGeneticsMesenchymal stem cell researchSpinal Cord Injury ResearchNerve injury and regeneration